chartexchange

XERS
Xeris Biopharma Holdings, Inc. Common Stock
stockNASDAQ

At CloseNov 19, 2026 3:59:59 PM EST
16.62USD-2.178%(-0.37)2,563,341
Pre-marketNov 19, 2026 9:27:30 AM EST
16.98USD-0.053%(-0.01)
After-hoursNov 19, 2026 4:00:30 PM EST
16.62USD0.000%(-0.00)
16.61Bid16.63Ask0.02Spread
Loading…
Loading…
Healthcare
Biotechnology
HQ
Chicago, IL, USA
Previous Close
$16.99
Beta
0.06
52-Week High
$17.28 2026-11-18
52-Week Low
$5.25 2026-03-25
SMA 50
$10.92
SMA 200
$7.97
Avg. Vol 10D
4.78M
Avg. Vol 30D
3.08M
Avg. Vol 90D
2.50M
Relative Vol
0.66
182.70M
173.47M
0.4300%
5,000,000
209,157
XERS Profile

xeris aspires to break through this restraint by developing ultra-low volume, ready-to-use biotherapeutics delivered through patient-friendly injectable devices. products built on our xeriject technologies could potentially ease the pain of injections for hundreds of millions of patients.

XERS Performance
PeriodPriceDateChangeBeta
1W16.652026-11-12-0.24%0.233
1M10.952026-10-19+51.69%-1.795
3M8.782026-08-19+89.18%-0.860
6M5.922026-05-19+180.57%-0.513
1Y7.092025-11-19+134.27%0.062
2Y3.012024-11-19+451.83%—
5Y2.272021-11-19+631.72%1.126
XERS Stock Summary

Xeris Biopharma Holdings, Inc. Common Stock (NASDAQ:XERS) stock price today is $16.61, and today's volume is 2,030,481. XERS is down 2.237% today. The 30 day average volume is 3.08M. XERS market cap is $3.03B with 182.70M shares outstanding.